Samir Tawadros

1.1k total citations
34 papers, 863 citations indexed

About

Samir Tawadros is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Samir Tawadros has authored 34 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Surgery. Recurrent topics in Samir Tawadros's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Samir Tawadros is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Samir Tawadros collaborates with scholars based in Germany, United States and Taiwan. Samir Tawadros's co-authors include Elke Pogge von Strandmann, Hinrich P. Hansen, Andreas Engert, Katrin S. Reiners, Venkateswara R. Simhadri, Peter Mallmann, Evgenia Isachenko, Vladimir Isachenko, Volker Diehl and Michael Hallek and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Samir Tawadros

34 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samir Tawadros Germany 16 352 254 225 155 142 34 863
Bruce R. Rowley United States 5 575 1.6× 331 1.3× 166 0.7× 59 0.4× 114 0.8× 7 950
Lowell J. Underwood United States 12 212 0.6× 420 1.7× 244 1.1× 30 0.2× 122 0.9× 16 881
Timothy J. O rsquo Brien United States 10 209 0.6× 376 1.5× 152 0.7× 32 0.2× 153 1.1× 10 651
Berend Neuteboom United States 13 286 0.8× 251 1.0× 476 2.1× 30 0.2× 202 1.4× 19 877
Jin-Yuh Shew Taiwan 12 170 0.5× 533 2.1× 470 2.1× 57 0.4× 40 0.3× 13 1.0k
Hiep Phuc Dong Norway 18 283 0.8× 327 1.3× 380 1.7× 42 0.3× 27 0.2× 33 928
John B. Beard United States 7 168 0.5× 302 1.2× 110 0.5× 30 0.2× 121 0.9× 8 513
Jérôme Giustiniani France 21 922 2.6× 259 1.0× 456 2.0× 84 0.5× 26 0.2× 45 1.4k
Satoshi Amada Japan 21 239 0.7× 402 1.6× 276 1.2× 97 0.6× 32 0.2× 38 1.5k
John McKolanis United States 12 682 1.9× 391 1.5× 558 2.5× 23 0.1× 168 1.2× 32 1.1k

Countries citing papers authored by Samir Tawadros

Since Specialization
Citations

This map shows the geographic impact of Samir Tawadros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samir Tawadros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samir Tawadros more than expected).

Fields of papers citing papers by Samir Tawadros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samir Tawadros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samir Tawadros. The network helps show where Samir Tawadros may publish in the future.

Co-authorship network of co-authors of Samir Tawadros

This figure shows the co-authorship network connecting the top 25 collaborators of Samir Tawadros. A scholar is included among the top collaborators of Samir Tawadros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samir Tawadros. Samir Tawadros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shatnyeva, Olga, Katrin S. Reiners, Samir Tawadros, et al.. (2016). Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activityin vitroandin vivoagainst chronic lymphocytic leukemia. OncoImmunology. 5(9). e1211220–e1211220. 18 indexed citations
2.
Schleimer, Karina, Johannes Kalder, Jochen Grommes, et al.. (2014). Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure. Journal of Visualized Experiments. 51115–51115. 3 indexed citations
3.
Reiners, Katrin S., Alexander Henke, Venkateswara R. Simhadri, et al.. (2013). Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity. Blood. 121(18). 3658–3665. 180 indexed citations
4.
Dietlein, Markus, Thomas Fischer, Hinrich P. Hansen, et al.. (2010). Entwicklung von Anti-CD30-Radioimmunkonstrukten zur Behandlung des Hodgkin-Lymphoms – Studien an Zellkulturen und Tieren. Nuklearmedizin - NuclearMedicine. 49(3). 97–105. 6 indexed citations
5.
Fischer, Thomas, Hinrich P. Hansen, R. Schnell, et al.. (2010). Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Nuklearmedizin - NuclearMedicine. 49(3). 97–105. 8 indexed citations
6.
Ullrich, Roland T., Thomas Zander, Bernd Neumaier, et al.. (2008). Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET). PLoS ONE. 3(12). e3908–e3908. 72 indexed citations
7.
Jensen, Markus, Sandra Schmitz, Samir Tawadros, et al.. (2007). One Step Generation of Fully Chimeric Antibodies Using Cγ1- and Cκ Mutant Mice. Journal of Immunotherapy. 30(3). 338–349. 2 indexed citations
8.
Tresckow, Bastian von, Elke Pogge von Strandmann, Stephanie Sasse, et al.. (2007). Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivo. Haematologica. 92(5). 682–685. 16 indexed citations
9.
Schleimer, Karina, Dirk L. Stippel, Samir Tawadros, et al.. (2006). Improved technique of heterotopic auxiliary rat liver transplantation with portal vein arterialization. Langenbeck s Archives of Surgery. 391(2). 102–107. 7 indexed citations
10.
Otto, Christina, Markus Jensen, Markus Dietlein, et al.. (2006). Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice. Nuclear Medicine Communications. 27(2). 171–178. 4 indexed citations
11.
12.
Borchmann, Peter, Roland Schnell, Samir Tawadros, et al.. (2004). Metalloproteinase inhibition augments antitumor efficacy of the anti‐CD30 immunotoxin Ki‐3(scFv)‐ETA′ against human lymphomas in vivo. International Journal of Cancer. 111(4). 568–574. 16 indexed citations
13.
Jensen, Markus, Samir Tawadros, Hans-Harald Sedlacek, Joachim L. Schultze, & Frank Berthold. (2004). NK cell depletion diminish tumour-specific B cell responses. Immunology Letters. 93(2-3). 205–210. 6 indexed citations
14.
Rahimi, G, Evgenia Isachenko, Vladimir Isachenko, et al.. (2004). Comparison of necrosis in human ovarian tissue after conventional slow freezing or vitrification and transplantation in ovariectomized SCID mice. Reproductive BioMedicine Online. 9(2). 187–193. 44 indexed citations
15.
Thomas, Roman K., Claudia Wickenhauser, Samir Tawadros, et al.. (2004). Mutational analysis of the IκBα gene in activated B cell‐like diffuse large B‐cell lymphoma. British Journal of Haematology. 126(1). 50–54. 12 indexed citations
16.
Bangard, Christopher, Axel Goßmann, A. Papyan, et al.. (2004). Magnetic resonance imaging in an orthotopic rat model: Blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth. International Journal of Cancer. 114(1). 131–138. 26 indexed citations
17.
Schleimer, Karina, Dirk L. Stippel, H. Kasper, et al.. (2004). Improved microcirculation of a liver graft by controlled portal vein arterialization. Journal of Surgical Research. 116(2). 202–210. 15 indexed citations
18.
Barth, Stefan, Michael Hühn, Samir Tawadros, et al.. (2000). Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice. Blood. 95(12). 3909–3914. 13 indexed citations
19.
Barth, Stefan, Michael Hühn, B. Matthey, et al.. (2000). Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID mice. International Journal of Cancer. 86(5). 718–724. 24 indexed citations
20.
Kapp, Ursula, Jürgen Wolf, Christof von Kalle, et al.. (1992). Preliminary report: Growth of Hodgkin's lymphoma derived cells in immune compromised mice. Annals of Oncology. 3. S21–S23. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce R. Rowley Breakdown of academic impact, for papers by Lowell J. Underwood Breakdown of academic impact, for papers by Timothy J. O rsquo Brien Breakdown of academic impact, for papers by Berend Neuteboom Breakdown of academic impact, for papers by Jin-Yuh Shew Breakdown of academic impact, for papers by Hiep Phuc Dong Breakdown of academic impact, for papers by John B. Beard Breakdown of academic impact, for papers by Jérôme Giustiniani Breakdown of academic impact, for papers by Satoshi Amada Breakdown of academic impact, for papers by John McKolanis
Rankless by CCL
2026